Tofacitinib citrate 540737-29-9 Rheumatoid arthritis Anticancer
Uku:T/T, L/C
Kumu Huahana:Kina
Awa moku:Pekina/Shanghai/Hangzhou
Hiki ke hana:100kg / mahina
Kauoha(MOQ):25 kg
Ka manawa o waena o ka hoʻomaka a i ka wā pau:3 Nā lā hana
Kūlana mālama:Hoʻopaʻa ʻia ma kahi anuanu, maloʻo, ka lumi wela.
Mea paʻa:pahu
Nui pūʻolo:25 kg/pahu
ʻIke palekana:ʻAʻole nā mea weliweli
Hoʻolauna
ʻO Tofacitinib, he lāʻau lapaʻau i hoʻohana ʻia e mālama i ka maʻi rheumatoid, psoriatic arthritis, a me ka ulcerative colitis.
Hoʻohana ʻia ka Tofacitinib citrate no ka mālama ʻana i nā poʻe mākua me ka maʻi rheumatoid maʻalahi a paʻakikī loa i loaʻa ka pane kūpono ʻole i ka methotrexate.
Hōʻike ʻia ʻo Tofacitinib citrate no ka mālama ʻana i ka maʻi rheumatoid maʻemaʻe a koʻikoʻi (RA) i loko o nā pākeke i pane kūpono ʻole, a i ʻole ka poʻe intolerant i hoʻokahi a i ʻole nā lāʻau antirheumatic hoʻololi i ka maʻi.
Hōʻike (ma ka hale)
| 'ikamu | Hōʻike |
| Ka nana aku | ʻO ka pauka kristal keʻokeʻo keʻokeʻo a keʻokeʻo paha |
| ʻIkepili | IR, HPLC |
| Wai | ≤1.5% |
| Na mea pili | TOFA 06 ≤0.15% |
| Tofacitinib trans isomer ≤0.15% | |
| Tofacitinib dehydrogenated ≤0.15% | |
| ʻO kēlā me kēia haumia ʻike ʻole ≤0.10% | |
| Huina haumia: ≤1.0% | |
| Nā mea hoʻoheheʻe koena | Ethanol ≤5000ppm |
| Benzene ≤2ppm | |
| Toluene ≤890ppm | |
| Chlroroethane ≤1000ppm | |
| N,N-Dimethylformamide ≤800ppm | |
| Palladium ≤10ppm | |
| Dichloromethane ≤600ppm | |
| Lehu sulphated | ≤0.1% |
| Metala Kaumaha | ≤10ppm |
| Chrial HPLC | 3S, 4S tofacitinib ≤0.15% |
| ʻIke (ma ke kumu anhydrous) 98.0-102.0% |
